Alimera Sciences reported $10.22M in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbvie ABBV:US $ 9517M 1089M
Aerie Pharmaceuticals AERI:US $ 23.06M 85.54M
Alimera Sciences ALIM:US $ 10.22M 1.78M
Bayer BAYN:GR 9.46B 2.03B
Insmed INSM:US $ 40.92M 1.92M
Novartis NOVN:VX 9.06B 463M
Regeneron Pharmaceuticals REGN:US $ 2560.2M 1408.9M